Invention Grant
- Patent Title: Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
-
Application No.: US15113297Application Date: 2015-01-21
-
Publication No.: US11084884B2Publication Date: 2021-08-10
- Inventor: Daniel J. Sexton , Burt Adelman , Yung Chyung , Christopher TenHoor , Jon A. Kenniston , Ryan Faucette , Ryan Iarrobino , Joseph Biedenkapp
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2015/012212 WO 20150121
- International Announcement: WO2015/112578 WO 20150730
- Main IPC: C07K16/40
- IPC: C07K16/40 ; A61K39/00
Abstract:
Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.
Public/Granted literature
- US20170002094A1 PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA Public/Granted day:2017-01-05
Information query
